Novavax, Inc. (NVAX)
7.46
-0.36
(-4.66%)
USD |
NASDAQ |
Jul 24, 16:00
7.50
+0.04
(+0.54%)
After-Hours: 20:00
Novavax EPS Diluted (Quarterly) : -0.0581 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0581 |
| December 31, 2025 | 0.1061 |
| September 30, 2025 | -1.246 |
| June 30, 2025 | 0.601 |
| March 31, 2025 | 2.920 |
| December 31, 2024 | -0.5057 |
| September 30, 2024 | -0.7579 |
| June 30, 2024 | 0.9948 |
| March 31, 2024 | -1.055 |
| December 31, 2023 | -1.442 |
| September 30, 2023 | -1.264 |
| June 30, 2023 | 0.5822 |
| March 31, 2023 | -3.411 |
| December 31, 2022 | -2.283 |
| September 30, 2022 | -2.154 |
| June 30, 2022 | -6.533 |
| March 31, 2022 | 2.520 |
| December 31, 2021 | -11.18 |
| September 30, 2021 | -4.314 |
| June 30, 2021 | -4.754 |
| March 31, 2021 | -3.050 |
| December 31, 2020 | -2.702 |
| September 30, 2020 | -3.206 |
| June 30, 2020 | -0.2989 |
| March 31, 2020 | -0.5822 |
| Date | Value |
|---|---|
| December 31, 2019 | -1.134 |
| September 30, 2019 | -0.7417 |
| June 30, 2019 | -1.687 |
| March 31, 2019 | -2.114 |
| December 31, 2018 | -2.575 |
| September 30, 2018 | -2.332 |
| June 30, 2018 | -2.40 |
| March 31, 2018 | -2.80 |
| December 31, 2017 | -3.20 |
| September 30, 2017 | -3.00 |
| June 30, 2017 | -3.20 |
| March 31, 2017 | -3.20 |
| December 31, 2016 | -4.20 |
| September 30, 2016 | -4.80 |
| June 30, 2016 | -5.80 |
| March 31, 2016 | -5.80 |
| December 31, 2015 | -5.80 |
| September 30, 2015 | -2.40 |
| June 30, 2015 | -1.60 |
| March 31, 2015 | -2.00 |
| December 31, 2014 | -2.60 |
| September 30, 2014 | -1.60 |
| June 30, 2014 | -1.60 |
| March 31, 2014 | -1.40 |
| December 31, 2013 | -1.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -3.40 |
| Pfizer Inc. | 0.4688 |
| Agenus, Inc. | 1.023 |
| Fate Therapeutics, Inc. | -0.26 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.491M |
| Revenue (Quarterly) | 139.51M |
| Total Expenses (Quarterly) | 149.00M |
| Enterprise Value | 731.32M |
| Gross Profit Margin (Quarterly) | 78.00% |
| Profit Margin (Quarterly) | -6.80% |
| Earnings Yield | -8.01% |
| Operating Earnings Yield | 2.99% |
| Normalized Earnings Yield | 0.1032 |